Literature DB >> 24788168

Assaying NF-κB activation and signaling from TNF receptors.

Zhenzhen Wu1, Leslie A Bruggeman.   

Abstract

Tumor necrosis factor (TNF)-mediated activation of the NF-κB family of transcription factors is mediated by two receptors, TNFR1 and TNFR2. These two receptors have unique roles in response to TNF and have been the focus of new therapeutic strategies in a variety of diseases with an immune or an inflammatory component. This chapter describes in vitro methods to functionally identify which TNF receptor is initiating NF-κB activation. This will include antibody-mediated receptor blockade and RNAi-mediated gene silencing targeting the individual receptors. The NF-κB activation methods presented include standard, accepted assays for monitoring the sequential activation steps through the NF-κB signal transduction cascade, including IκBα degradation, NF-κB nuclear translocation, and transcriptional activation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788168     DOI: 10.1007/978-1-4939-0669-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment.

Authors:  Yang Qu; Gang Zhao; Hui Li
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

2.  RELT promotes the growth of esophageal squamous cell carcinoma by activating the NF-κB pathway.

Authors:  Wenjian Yao; Qing Chen; Saisai Li; Xiangbo Jia; Lei Xu; Li Wei
Journal:  Cell Cycle       Date:  2021-06-13       Impact factor: 5.173

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.